The shares of AveXis, Inc. (AVXS) traded with a loss of -0.08 points or -0.14% in the most recent session. The shares last traded at $55.7. As per the trading info, the shares saw $1.74 million in upticks and lost $0.09 million in downticks, resulting in a net money flow of $1.65 million. The up/down ratio for the day was measured at 19.43. For the week, the shares had posted 1.27%.From the block trade data available, the total upticks were valued at $1.39 million and the total downticks were valued at $0 million, thereby putting the up/down ratio at 0. The net money flow for the block transaction was $1.39 million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
AveXis, Inc. (NASDAQ:AVXS) rose 2.96% or 1.65 points on Wednesday and made its way into the gainers of the day. After trading began at $56.11 the stock was seen hitting $58.43 as a peak level and $55.15 as the lowest level. The stock ended up at $57.43. The daily volume was measured at 554,089 shares. The 52-week high of the share price is $72.725 and the 52-week low is $16.11. The company has a market cap of $1,589 million.
AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Companys product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant mortality. AveXis, Inc. is headquartered in Bannockburn, Illinois.